SlideShare a Scribd company logo
Manufacturer Evidence and applications for
inclusion in the ARTG
Medical Devices
Susan Barker
Devices Application and Verification Section
Medical Devices Branch
Devices Sponsor Information Day
11 October 2017
Purpose
Facilitate better understanding of the regulatory
requirements for medical devices
ARTG inclusion – explain the process and give
some examples
2
Overview
• Key definitions and regulatory framework
• Manufacturer’s Evidence
• Information in an application
• Avoiding common problems in applications
3
What is a medical device?
• Used for human beings
• Intended purpose
– Diagnosis, prevention, monitoring, treatment or alleviation of disease or compensation for injury
or disability
– Investigation, replacement or modification of anatomy or physiological processes
– Control of conception
• Principal intended action
– Not by pharmacological, immunological or metabolic means
• Definition of IVD in the MD Regulations
• Products declared to be or not to be a medical device
– Therapeutic Goods (Articles that are Medical Devices) Specification and/or
Therapeutic Goods (Articles that are not Medical Devices) Orders
• Accessory to a medical device as described above
Therapeutic Goods Act 1989, section 41BD 4
What is an IVD?
• A reagent, calibrator, control material, kit, specimen receptacle, instrument,
software, equipment or system
• Intended for the in vitro examination of human specimens for
– giving information about a physiological or pathological state
– giving information about a congenital abnormality
– determining safety and compatibility with a potential recipient
– monitoring therapeutic measures
Therapeutic Goods (Medical Devices) Regulations 2002, Dictionary
5
ARTG inclusion
• Any medical device must be included in ARTG
• Except:
- Exempt devices (e.g. custom-made medical devices)
• Sponsor is responsible for ARTG inclusion
• Before you start
• TGA Business Services (TBS)
– Register and get your Client ID
6
Process for ARTG inclusion
Basics - process through TGA
7
Manufacturer evidence
• Manufacturer must apply appropriate conformity assessment procedure to the device
(quality management system and control over the design of the device)
• Sponsor must lodge the manufacturer’s certification of the conformity assessment with the
TGA
- Except for Class I medical devices (no measuring function and/or not supplied sterile),
Class 1 IVD, and/or Export Only
• TGA conformity assessment certificate
• EC Certificate issued under MDD 93/42/EEC, AIMDD 90/385/EEC, IVD 98/79/EC
• MRA certificates issued by EU Notified Body (with certain exceptions)
• Declarations of conformity made under Clause 7.5 of Schedule 3 (systems or procedure
packs)
• ISO 13485 for IVDs only 8
Manufacturer Evidence
Submitted
Accepted
−What does it mean?
Go to the next step - lodging application
for ARTG inclusion
9
Application for ARTG inclusion
• Must be made for a kind of device and
• Must be made in accordance with a form and manner approved (via
TBS) and
• Application fee must be paid and
• For the devices that must have TGA conformity assessment certificate
– such certificate is in force and
• Must not contain information that is false or misleading in a material
particular
Therapeutic Goods Act 1989, sections 41FC and 41EA, and Therapeutic Goods (Medical Devices) Regulations 2002, regulation 4.1
10
What we look at
Kind of device
Intended Purpose
GMDN Code
Device Product Characteristics
Classification
Conformity Assessment Procedures
11
Kind of device
• Sponsor
• Manufacturer
• Device nomenclature system code (GMDN)
• Classification
• Unique product identifier (UPI)
(for Class III and active implantable medical devices (AIMD), and
Class 4IVD, except immunohaematology reagent)
a medical device is taken to
be of the same kind as
another medical device if
they have the same:
Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical
Devices) Regulations 2002, regulations 1.6 and 1.7 12
Intended purpose of a kind of device
• Means the purpose for which the manufacturer of the device intends
it to be used, as stated in the information provided with the device
(labelling, instructions for use, advertising material and technical
documentation)
• Intended purpose stated in the application must be consistent with
the purpose for which the manufacturer intends the devices of the kind
to be used
Note: The manufacturer must have evidence that the device
performs as intended (refer essential principles)
13
Global Medical Device Nomenclature (GMDN)
- One of the characteristics that defines the kind of device
- Is to be consistent with the intended purpose of the device
- Must be the code that best describes the kind of device
- For medical devices (not-IVD) – relevant preferred term (except Class
I – relevant template term)
- For IVDs - collective terms (Level 1, 2 or 3) (except
Class 4IVD that is not immunohaematology reagent - relevant
preferred term)
Manufacturer’s responsibility 14
Device Product Characteristics
• Ensure ‘Device Product Characteristics’ section in the application is
correctly filled in
15
Medical devices are classified having regard to
the intended purpose of the device
Class I Class Is and
Class Im
Class IIa Class IIb Class III and
AIMD
The lowest level The highest level
Therapeutic Goods (Medical Devices) Regulations 2002, Part 3
Division 3.1 and Schedules 2 16
IVD medical devices are classified having regard to the
intended purpose of the device and its risk to public health
and/or personal risk
• Class 1 IVD – no public health risk or low personal risk
• Class 2 IVD – low public health risk or moderate personal risk
• Class 3 IVD – moderate public health risk or high personal risk
• Class 4 IVD – high public health risk
RISK
Therapeutic Goods (Medical Devices) Regulations 2002, Schedules 2A
17
Conformity assessment procedure
• Minimum conformity assessment procedures for different Classes
of devices
• Sufficient information to demonstrate application of the appropriate
conformity assessment procedures to the kind of device
Part 3 Division 3.2 and Schedule 3, Therapeutic Goods (Medical Devices) Regulations 2002
18
Conformity assessment procedures
• Minimum conformity assessment procedures for different Classes of
devices
Class Is device
(e.g. Sterile surgical gown)
Class III device
supplied sterile
(e.g. Knee Femur)
Annex II.3 - Full Quality Assurance
Annex V – Production Quality
Plus
Declaration of conformity
(Part 6, Schedule 3)
Annex III - Type Examination
Plus:
Annex V - Production Quality Assurance
Annex II.3 - Full Quality Assurance
Plus
Annex II.4 - Examination of Design
OR
OR
19
One page document
• Describe the device and intended purpose if needed in more detail
• Cite the classification rules in accordance with
Schedule 2 or 2A of the Regulations and provide justification where
required
• Explain how the kind of device is covered under the scope of certificate
included in Manufacturer’s Evidence
• Make sure all the information is complete and correct
• Do not attach more than one page
20
Information provided in the application
• Do not attach information that is not relevant with the
application, for example:
– Declaration of conformity made under EU Medical Device
Directive
– Audit and/or technical data reports
• Ensure intended purpose is clear and correct
• Ensure the device is classified correctly
• Ensure the Manufacturer’s Evidence stated in the application
contains correct certificate
21
Examples of common mistakes
Incorrect Device
Product Characteristics
GMDN code not most
relevant for the kind of
device
Incorrect Classification
Scope of EC certificate
does not correctly cover
the kind of device
Attaching documents not
relevant, which do not
meet requirements
22
Where do we go from here?
Matters certified under s.41FD
Ensure all information provided is correct
Any application may be selected for audit
Some applications must be selected for audit
23
SME Assist
• Guidance on TGA website
• Interactive online tool
24
Further information
• Medical devices (http://www.tga.gov.au/medical-devices-ivds)
• SME Assist (https://www.tga.gov.au/sme-assist)
TGA website
• Therapeutic Goods Act 1989 Chapter 3, Part 4-5
• Therapeutic Goods (Medical Devices) Regulations 2002
Federal Register of Legislation
• devices@tga.gov.au ph.: 1800 141 144
Contact the TGA Medical Devices Branch
25
Thank you!
26
TGA Presentation: Medical Devices - Manufacturer Evidence and applications for inclusion in the ARTG
Juliana William
Sr RA Associate
Baxter Healthcare
11/10/2017 Devices Sponsor Information Day 28
Agenda
Successful and Efficient Submission
 Preparation
 Checks to do
 Additional information
 Non-mandatory audit submissions
This presentation will not cover details of:
• Systems and Procedure Packs
• Conformity Assessment
• Audit Assessment
• Class III/AIMD, UPI and Variants
• Clinical Evidence & Risk Assessment compliance
11/10/2017 Devices Sponsor Information Day 29
Common Deficiencies
Manufacturer Evidence
(ME)
• Two or more
certificates are
provided
• EU declaration of
Conformity
• ISO 13485 certificate
• Incomplete certificate
(missing attachments)
• Incorrect annex route
• Incorrect directive
• Not in English!
Device Application
(DA)
• GMDN code does no
match the ‘Intended
purpose’
• Wrong classification
• Device is not covered in
the EC Certificate scope
• Route of conformity (EC
Certificate Annex) is not
appropriate for the
proposed Class
• Wrong manufacturer
evidence!
Administrative
• Missing documents or
pages!
• TGA evaluator unable to
find information easily
• Poor hyperlinking and
bookmarking
• Spelling errors
• Poor English Translation
• Missing signatures!
• Application fees not
processed
11/10/2017 Devices Sponsor Information Day 30
Preparation
 Ensure a legal/quality/distribution agreement is/are in place which outline
clearly roles and responsibilities for post-market monitoring, vigilance and
reporting obligations
 Obtain Australian Declaration of Conformity from manufacturer
 Make sure you have the right template for class and conformity route. See
http://www.tga.gov.au/industry/devices-forms-declaration-conformity.htm
 Ensure the codes listed are the code to be registered and marketed
 Obtain Australian Essential Principles Checklist from manufacturer
● Ensure compliance with all standards applied and compliance with the Australian EP. Section 8 of the ARGMD
explain the differences between EU ER and Australia EP.
 Product Labelling and Instruction for Use
 Risk Management Report and Clinical Evaluation Report
11/10/2017 Devices Sponsor Information Day 31
Checks to Do
 Check whether the device:
 Sterile? What is the sterilisation method
 Measuring function?
 Invasive?
 Reusable or Single Use?
 Active?
 Single product or System or Procedure pack?
 Contains a medicine?
 Contains material or ingredients of microbial/ recombinant / GMO/ animal/ human
origin? Country of origin?
 Is the device classified correctly according to the TGA Classification
Rules? (Schedule 2 of The Regulations)
11/10/2017 Devices Sponsor Information Day 32
Checks to Do
The medical devices regulatory
framework has a classification system
for medical devices.
The detailed legislation is in:
• 41BD of the Therapeutic Goods Act
1989 (the Act)
• Regulation 3.2 of the Therapeutic
Goods (Medical Devices)
Regulations 2002 (the Regulations)
• Schedule 2 of the Regulations.
11/10/2017 Devices Sponsor Information Day 33
Checks to Do
• Is the assigned GMDN code appropriate? (Section 10 of the Regulation)
 Remember that manufacturer assign the GMDN code.
 Check if the GMDN is on the TGA database. If the GMDN code is not in the TGA database,
ask for it to be added in advance by email to ebs@tga.gov.au
 There may be differences between the GMDN Agency code table database and the TGA code
table database.
 Based on the Device information, is the GMDN appropriate and reflects the intended
purpose?
 Must be a preferred term
 Does the device perform according to its intended purpose?
 This should be a detailed description of the manufacturers intended purpose and should closely
align with the relevant GMDN description
 Remember: Intended purpose is different from Functional description (describes the
operation of the medical device, not its composition)
11/10/2017 Devices Sponsor Information Day 34
Checks to Do
● Is the device same kind of medical device (Section 41BE of The Act)?
A medical device is of the same ‘kind’ if it has the same:
 Intended purpose
 Classification
 GMDN code
 Legal manufacturer
 Sponsor
 Does it have appropriate evidence of Conformity Assessment?
 ARGMD Section 5 Conformity Assessment Overview
 Need to check the appropriate level and route is held by the manufacturer
according to the classification
11/10/2017 Devices Sponsor Information Day 35
Checks to Do
11/10/2017 Devices Sponsor Information Day 36
Checks to Do
There are a number of
important details that a
sponsor should check to
ensure that the certificate
is valid for particular
devices.
Refer to Section 7 of the
ARGMD
11/10/2017 Devices Sponsor Information Day 37
Additional Information
If there is additional information that could help the assessor, then it would
be beneficial to attach a ONE PAGE ONLY document with the application
illustrating:
 A Picture/diagram of the device
 A description of the device (not the intended purpose)
 A description of the mechanism of action (how it works)
 How the device is included in the scope of the CE Certificate
 Evidence of the same kind of medical device (for multiple devices)
11/10/2017 Devices Sponsor Information Day 38
Non-mandatory audit
 Any Device Application is subject to non-mandatory audit.
 Be prepared to submit any documents from Level 1 or 2 audit list, as well as anything else you may
need to show compliance with any of the Essential Principles or Conformity Assessment
Procedures.
Examples:
 Compliance with Essential Principles
 Notified Body audit reports to verify the validity of the EC Certificate
 Product labelling and IFU
 Explanation and justification of Classification
 Recent Clinical Evaluation Report
 Recent Risk Management File
 Compliance with particular standards (or justification why it is not complied with)
 Remember you declare you can submit in 20 days!
11/10/2017 Devices Sponsor Information Day 39
Non-mandatory audit
 Provides all items requested by the TGA
 Electronic and easy to navigate (entire document):
 Clear table of content (hyperlinking and bookmarking work!)
 Text readable
 Page numbers throughout
 Up-to-date Clinical Evidence Report (signed by a clinical expert!)
 Up-to-date Risk Management File
 Well prepared submission will:
 Allow the delegate to easily navigate and find information quickly.
 Reduce the number of questions raised by the delegate
 Speed approval
The better quality the submission, the easier it is to read and evaluate
11/10/2017 Devices Sponsor Information Day 40
Wrap Up
 Make sure you understand your product.
 Do your preparation and verify information before submission! Time spent before submitting
is well worth it and will increase your success rate
 Engage your cross function team (R&D/Quality/Medical/Clinical..etc) well in advance of your
submission plan. Discuss application requirements and TGA’s expectation.
 Submit meaningful, helpful and well-set out information. Perform second check before sending
application and electronic files
 Clearly explain the scope of your application in the cover letter
 Provide comprehensive Table of Content
 Ensure all hyperlinks and bookmarks are actually working
 Ensure all documents and attachments are provided with the application!
 Don’t submit extra documents that aren’t useful or haven’t been requested
11/10/2017 Devices Sponsor Information Day 41
References
The Act
Therapeutic Goods Act 1989
The Regulations
Therapeutic Goods (Medical Device) Regulations 2002
ARGMD
Australian Regulatory Guidance for Medical Devices
11/10/2017 Devices Sponsor Information Day 42
Questions?
11/10/2017 Devices Sponsor Information Day 43

More Related Content

PPTX
FDA Warning letter
PPTX
REGULATORY CONSIDERATIONS IN JAPAN.pptx
PPTX
FDA Warning Letter
PPTX
CE marking and CE certification
PPTX
Post Marketing Requirements/Complaince: PMRs and PMCs
PPTX
EU Medical Device Regulatory Framework_Dec, 2022
PPTX
Medical Device Exemption and Post Marketing Survelliance
PPTX
GHTF
FDA Warning letter
REGULATORY CONSIDERATIONS IN JAPAN.pptx
FDA Warning Letter
CE marking and CE certification
Post Marketing Requirements/Complaince: PMRs and PMCs
EU Medical Device Regulatory Framework_Dec, 2022
Medical Device Exemption and Post Marketing Survelliance
GHTF

What's hot (20)

PDF
Medical Device Regulatory Approval
PPTX
Medical Device Regulations - 510(k) Process
PDF
How to Prepare for the New EU Medical Device Regulations (MDR)
PPTX
Regulatory approval process for invitro diagnostics in us
PPTX
European_Union.ppt.Nikhil[1].pptx
PPTX
ISO Standard 13485
PPTX
21 CFR PART 50.pptx
PDF
ISO 14155 Clinical investigation of medical devices for human subjects- Good ...
PDF
GMP for Nutraceuticals .pdf
PPTX
The regulation of medical devices in Australia
PPTX
Clinical investigation and evaluation of medical devices and ivd.pptx
PPTX
Plasma drug file and TSE/ BSE evaluation
PPTX
21 CFR 820....pptx
PDF
The European Medical Device Regulations - analysis of the final text
 
PPTX
Post marketing surveillance in Japan, legislation and.pptx
PDF
Software as a Medical Device (SaMD) - IMDRF Definition and Categorisation
 
PPTX
Medical devices CHINA
PPTX
Medical Device Regulation (MDR) overview for Technion, May 25, 2021
PDF
21 CFR 820 and 801 pptx.pdf
Medical Device Regulatory Approval
Medical Device Regulations - 510(k) Process
How to Prepare for the New EU Medical Device Regulations (MDR)
Regulatory approval process for invitro diagnostics in us
European_Union.ppt.Nikhil[1].pptx
ISO Standard 13485
21 CFR PART 50.pptx
ISO 14155 Clinical investigation of medical devices for human subjects- Good ...
GMP for Nutraceuticals .pdf
The regulation of medical devices in Australia
Clinical investigation and evaluation of medical devices and ivd.pptx
Plasma drug file and TSE/ BSE evaluation
21 CFR 820....pptx
The European Medical Device Regulations - analysis of the final text
 
Post marketing surveillance in Japan, legislation and.pptx
Software as a Medical Device (SaMD) - IMDRF Definition and Categorisation
 
Medical devices CHINA
Medical Device Regulation (MDR) overview for Technion, May 25, 2021
21 CFR 820 and 801 pptx.pdf
Ad

Viewers also liked (8)

PDF
Presentation: Clinical Evidence Guidelines
PPTX
TGA presentation: medical devices audit assessments
PDF
Presentation: Conformity Assessment Evidence
PPTX
TGA presentation: Lifecycle of a Medical Device / IVD
PPTX
TGA presentation: The role of the TGA
PPTX
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
PPTX
Harry Surden - Artificial Intelligence and Law Overview
PPTX
Inside Google's Numbers in 2017
Presentation: Clinical Evidence Guidelines
TGA presentation: medical devices audit assessments
Presentation: Conformity Assessment Evidence
TGA presentation: Lifecycle of a Medical Device / IVD
TGA presentation: The role of the TGA
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
Harry Surden - Artificial Intelligence and Law Overview
Inside Google's Numbers in 2017
Ad

Similar to TGA Presentation: Medical Devices - Manufacturer Evidence and applications for inclusion in the ARTG (20)

PPTX
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
PPTX
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
PPTX
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
PPTX
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
PPTX
The regulation of IVD medical devices
PDF
TGA webinar presentation: Regulation of software, including software as a med...
PPTX
The challenges of regulating direct to consumer digital medical devices
PPTX
Presentation: The challenges of regulating direct to consumer digital medical...
PDF
Presentation: Software as a Medical Device: Regulatory insights and Q & A
PPTX
Presentation: Therapeutic Goods Administration: An introduction to the work o...
PPTX
regulatoryapprovalprocessformdineu-150120223330-conversion-gate02.pptx
PPTX
Devices Sponsor Information Day: 0 - Developments in medical device regulation
PDF
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
PDF
Regulatory approval process for medical Devices
PPTX
Presentation: Navigating regulation
PPTX
Devices Sponsor Information Day: 1 - Conformity Assessment
PDF
mHealth Summit EU 2015
PPTX
Presentation: Conformity assessment evidence
PPTX
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
PDF
Presentation_Medical device registartion Malaysia.pdf
Devices Sponsor Information Day: 3A - Medical Devices - Manufacturer's eviden...
Devices Sponsor Information Day: Session 3B: Medical devices (IVDs) - applica...
Devices Sponsor Information Day - Medical Devices (IVDs) - Applications for A...
Sponsor Information and Training day Session A1 – Medical Devices: Efficient ...
The regulation of IVD medical devices
TGA webinar presentation: Regulation of software, including software as a med...
The challenges of regulating direct to consumer digital medical devices
Presentation: The challenges of regulating direct to consumer digital medical...
Presentation: Software as a Medical Device: Regulatory insights and Q & A
Presentation: Therapeutic Goods Administration: An introduction to the work o...
regulatoryapprovalprocessformdineu-150120223330-conversion-gate02.pptx
Devices Sponsor Information Day: 0 - Developments in medical device regulation
Regulatory Approval Process for Medical Devices in EU - Presentation by Aksha...
Regulatory approval process for medical Devices
Presentation: Navigating regulation
Devices Sponsor Information Day: 1 - Conformity Assessment
mHealth Summit EU 2015
Presentation: Conformity assessment evidence
Devices Sponsor Information Day: 4A - Medical Devices - Audit assessments
Presentation_Medical device registartion Malaysia.pdf

More from TGA Australia (20)

PPTX
Pharmacovigilance and complementary medicines - Regulatory requirements
PPTX
Updates from the Pharmacovigilance and Special Access Branch
PPTX
Consumer Medicine Information - Improving the CMI template
PPTX
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
PPTX
Improved electronic submission methodologies - Challenges and future state
PPTX
Regulation, ethics and reimbursement of novel biological therapies in Austral...
PPTX
Updates to Good Manufacturing Practices - Recent, current and future changes
PPTX
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
PPTX
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
PPTX
Update on regulatory reforms from the Scientific Evaluation Branch
PPTX
Update on regulatory reforms from the Scientific Evaluation Branch
PPTX
Reporting of Medicine Shortages
PPTX
Regulatory updates from the TGA Medical Devices Branch - Part 1
PPTX
Regulatory updates from the TGA Medical Devices Branch - Part 2
PPTX
SME Assist: Help to navigate the regulatory maze
PPTX
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
PPTX
Presentation: Updates from the Pharmacovigilance and Special Access Branch
PPTX
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
PPTX
Webinar presentation: Consultation on reforms to the generic medicine market ...
PPTX
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Pharmacovigilance and complementary medicines - Regulatory requirements
Updates from the Pharmacovigilance and Special Access Branch
Consumer Medicine Information - Improving the CMI template
Regulatory updates from the Complementary and OTC Medicines Branch - Listed m...
Improved electronic submission methodologies - Challenges and future state
Regulation, ethics and reimbursement of novel biological therapies in Austral...
Updates to Good Manufacturing Practices - Recent, current and future changes
Good Clinical Practice Inspections - Consultation to introduce a pilot progra...
Manufacturing Investigational Medicinal Products - Legislative and GMP requir...
Update on regulatory reforms from the Scientific Evaluation Branch
Update on regulatory reforms from the Scientific Evaluation Branch
Reporting of Medicine Shortages
Regulatory updates from the TGA Medical Devices Branch - Part 1
Regulatory updates from the TGA Medical Devices Branch - Part 2
SME Assist: Help to navigate the regulatory maze
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
Presentation: Updates from the Pharmacovigilance and Special Access Branch
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
Webinar presentation: Consultation on reforms to the generic medicine market ...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...

Recently uploaded (20)

PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PPT
Obstructive sleep apnea in orthodontics treatment
PDF
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
PPTX
1 General Principles of Radiotherapy.pptx
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
Uterus anatomy embryology, and clinical aspects
PPTX
History and examination of abdomen, & pelvis .pptx
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPTX
post stroke aphasia rehabilitation physician
PPTX
Neuropathic pain.ppt treatment managment
PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
Important Obstetric Emergency that must be recognised
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPT
Management of Acute Kidney Injury at LAUTECH
PPTX
Gastroschisis- Clinical Overview 18112311
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PPTX
Slider: TOC sampling methods for cleaning validation
neonatal infection(7392992y282939y5.pptx
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
Obstructive sleep apnea in orthodontics treatment
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
1 General Principles of Radiotherapy.pptx
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Uterus anatomy embryology, and clinical aspects
History and examination of abdomen, & pelvis .pptx
CT Anatomy for Radiotherapy.pdf eryuioooop
post stroke aphasia rehabilitation physician
Neuropathic pain.ppt treatment managment
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
CME 2 Acute Chest Pain preentation for education
Important Obstetric Emergency that must be recognised
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
Management of Acute Kidney Injury at LAUTECH
Gastroschisis- Clinical Overview 18112311
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
Slider: TOC sampling methods for cleaning validation

TGA Presentation: Medical Devices - Manufacturer Evidence and applications for inclusion in the ARTG

  • 1. Manufacturer Evidence and applications for inclusion in the ARTG Medical Devices Susan Barker Devices Application and Verification Section Medical Devices Branch Devices Sponsor Information Day 11 October 2017
  • 2. Purpose Facilitate better understanding of the regulatory requirements for medical devices ARTG inclusion – explain the process and give some examples 2
  • 3. Overview • Key definitions and regulatory framework • Manufacturer’s Evidence • Information in an application • Avoiding common problems in applications 3
  • 4. What is a medical device? • Used for human beings • Intended purpose – Diagnosis, prevention, monitoring, treatment or alleviation of disease or compensation for injury or disability – Investigation, replacement or modification of anatomy or physiological processes – Control of conception • Principal intended action – Not by pharmacological, immunological or metabolic means • Definition of IVD in the MD Regulations • Products declared to be or not to be a medical device – Therapeutic Goods (Articles that are Medical Devices) Specification and/or Therapeutic Goods (Articles that are not Medical Devices) Orders • Accessory to a medical device as described above Therapeutic Goods Act 1989, section 41BD 4
  • 5. What is an IVD? • A reagent, calibrator, control material, kit, specimen receptacle, instrument, software, equipment or system • Intended for the in vitro examination of human specimens for – giving information about a physiological or pathological state – giving information about a congenital abnormality – determining safety and compatibility with a potential recipient – monitoring therapeutic measures Therapeutic Goods (Medical Devices) Regulations 2002, Dictionary 5
  • 6. ARTG inclusion • Any medical device must be included in ARTG • Except: - Exempt devices (e.g. custom-made medical devices) • Sponsor is responsible for ARTG inclusion • Before you start • TGA Business Services (TBS) – Register and get your Client ID 6
  • 7. Process for ARTG inclusion Basics - process through TGA 7
  • 8. Manufacturer evidence • Manufacturer must apply appropriate conformity assessment procedure to the device (quality management system and control over the design of the device) • Sponsor must lodge the manufacturer’s certification of the conformity assessment with the TGA - Except for Class I medical devices (no measuring function and/or not supplied sterile), Class 1 IVD, and/or Export Only • TGA conformity assessment certificate • EC Certificate issued under MDD 93/42/EEC, AIMDD 90/385/EEC, IVD 98/79/EC • MRA certificates issued by EU Notified Body (with certain exceptions) • Declarations of conformity made under Clause 7.5 of Schedule 3 (systems or procedure packs) • ISO 13485 for IVDs only 8
  • 9. Manufacturer Evidence Submitted Accepted −What does it mean? Go to the next step - lodging application for ARTG inclusion 9
  • 10. Application for ARTG inclusion • Must be made for a kind of device and • Must be made in accordance with a form and manner approved (via TBS) and • Application fee must be paid and • For the devices that must have TGA conformity assessment certificate – such certificate is in force and • Must not contain information that is false or misleading in a material particular Therapeutic Goods Act 1989, sections 41FC and 41EA, and Therapeutic Goods (Medical Devices) Regulations 2002, regulation 4.1 10
  • 11. What we look at Kind of device Intended Purpose GMDN Code Device Product Characteristics Classification Conformity Assessment Procedures 11
  • 12. Kind of device • Sponsor • Manufacturer • Device nomenclature system code (GMDN) • Classification • Unique product identifier (UPI) (for Class III and active implantable medical devices (AIMD), and Class 4IVD, except immunohaematology reagent) a medical device is taken to be of the same kind as another medical device if they have the same: Therapeutic Goods Act 1989, section 41BE and Therapeutic Goods (Medical Devices) Regulations 2002, regulations 1.6 and 1.7 12
  • 13. Intended purpose of a kind of device • Means the purpose for which the manufacturer of the device intends it to be used, as stated in the information provided with the device (labelling, instructions for use, advertising material and technical documentation) • Intended purpose stated in the application must be consistent with the purpose for which the manufacturer intends the devices of the kind to be used Note: The manufacturer must have evidence that the device performs as intended (refer essential principles) 13
  • 14. Global Medical Device Nomenclature (GMDN) - One of the characteristics that defines the kind of device - Is to be consistent with the intended purpose of the device - Must be the code that best describes the kind of device - For medical devices (not-IVD) – relevant preferred term (except Class I – relevant template term) - For IVDs - collective terms (Level 1, 2 or 3) (except Class 4IVD that is not immunohaematology reagent - relevant preferred term) Manufacturer’s responsibility 14
  • 15. Device Product Characteristics • Ensure ‘Device Product Characteristics’ section in the application is correctly filled in 15
  • 16. Medical devices are classified having regard to the intended purpose of the device Class I Class Is and Class Im Class IIa Class IIb Class III and AIMD The lowest level The highest level Therapeutic Goods (Medical Devices) Regulations 2002, Part 3 Division 3.1 and Schedules 2 16
  • 17. IVD medical devices are classified having regard to the intended purpose of the device and its risk to public health and/or personal risk • Class 1 IVD – no public health risk or low personal risk • Class 2 IVD – low public health risk or moderate personal risk • Class 3 IVD – moderate public health risk or high personal risk • Class 4 IVD – high public health risk RISK Therapeutic Goods (Medical Devices) Regulations 2002, Schedules 2A 17
  • 18. Conformity assessment procedure • Minimum conformity assessment procedures for different Classes of devices • Sufficient information to demonstrate application of the appropriate conformity assessment procedures to the kind of device Part 3 Division 3.2 and Schedule 3, Therapeutic Goods (Medical Devices) Regulations 2002 18
  • 19. Conformity assessment procedures • Minimum conformity assessment procedures for different Classes of devices Class Is device (e.g. Sterile surgical gown) Class III device supplied sterile (e.g. Knee Femur) Annex II.3 - Full Quality Assurance Annex V – Production Quality Plus Declaration of conformity (Part 6, Schedule 3) Annex III - Type Examination Plus: Annex V - Production Quality Assurance Annex II.3 - Full Quality Assurance Plus Annex II.4 - Examination of Design OR OR 19
  • 20. One page document • Describe the device and intended purpose if needed in more detail • Cite the classification rules in accordance with Schedule 2 or 2A of the Regulations and provide justification where required • Explain how the kind of device is covered under the scope of certificate included in Manufacturer’s Evidence • Make sure all the information is complete and correct • Do not attach more than one page 20
  • 21. Information provided in the application • Do not attach information that is not relevant with the application, for example: – Declaration of conformity made under EU Medical Device Directive – Audit and/or technical data reports • Ensure intended purpose is clear and correct • Ensure the device is classified correctly • Ensure the Manufacturer’s Evidence stated in the application contains correct certificate 21
  • 22. Examples of common mistakes Incorrect Device Product Characteristics GMDN code not most relevant for the kind of device Incorrect Classification Scope of EC certificate does not correctly cover the kind of device Attaching documents not relevant, which do not meet requirements 22
  • 23. Where do we go from here? Matters certified under s.41FD Ensure all information provided is correct Any application may be selected for audit Some applications must be selected for audit 23
  • 24. SME Assist • Guidance on TGA website • Interactive online tool 24
  • 25. Further information • Medical devices (http://www.tga.gov.au/medical-devices-ivds) • SME Assist (https://www.tga.gov.au/sme-assist) TGA website • Therapeutic Goods Act 1989 Chapter 3, Part 4-5 • Therapeutic Goods (Medical Devices) Regulations 2002 Federal Register of Legislation • devices@tga.gov.au ph.: 1800 141 144 Contact the TGA Medical Devices Branch 25
  • 28. Juliana William Sr RA Associate Baxter Healthcare 11/10/2017 Devices Sponsor Information Day 28
  • 29. Agenda Successful and Efficient Submission  Preparation  Checks to do  Additional information  Non-mandatory audit submissions This presentation will not cover details of: • Systems and Procedure Packs • Conformity Assessment • Audit Assessment • Class III/AIMD, UPI and Variants • Clinical Evidence & Risk Assessment compliance 11/10/2017 Devices Sponsor Information Day 29
  • 30. Common Deficiencies Manufacturer Evidence (ME) • Two or more certificates are provided • EU declaration of Conformity • ISO 13485 certificate • Incomplete certificate (missing attachments) • Incorrect annex route • Incorrect directive • Not in English! Device Application (DA) • GMDN code does no match the ‘Intended purpose’ • Wrong classification • Device is not covered in the EC Certificate scope • Route of conformity (EC Certificate Annex) is not appropriate for the proposed Class • Wrong manufacturer evidence! Administrative • Missing documents or pages! • TGA evaluator unable to find information easily • Poor hyperlinking and bookmarking • Spelling errors • Poor English Translation • Missing signatures! • Application fees not processed 11/10/2017 Devices Sponsor Information Day 30
  • 31. Preparation  Ensure a legal/quality/distribution agreement is/are in place which outline clearly roles and responsibilities for post-market monitoring, vigilance and reporting obligations  Obtain Australian Declaration of Conformity from manufacturer  Make sure you have the right template for class and conformity route. See http://www.tga.gov.au/industry/devices-forms-declaration-conformity.htm  Ensure the codes listed are the code to be registered and marketed  Obtain Australian Essential Principles Checklist from manufacturer ● Ensure compliance with all standards applied and compliance with the Australian EP. Section 8 of the ARGMD explain the differences between EU ER and Australia EP.  Product Labelling and Instruction for Use  Risk Management Report and Clinical Evaluation Report 11/10/2017 Devices Sponsor Information Day 31
  • 32. Checks to Do  Check whether the device:  Sterile? What is the sterilisation method  Measuring function?  Invasive?  Reusable or Single Use?  Active?  Single product or System or Procedure pack?  Contains a medicine?  Contains material or ingredients of microbial/ recombinant / GMO/ animal/ human origin? Country of origin?  Is the device classified correctly according to the TGA Classification Rules? (Schedule 2 of The Regulations) 11/10/2017 Devices Sponsor Information Day 32
  • 33. Checks to Do The medical devices regulatory framework has a classification system for medical devices. The detailed legislation is in: • 41BD of the Therapeutic Goods Act 1989 (the Act) • Regulation 3.2 of the Therapeutic Goods (Medical Devices) Regulations 2002 (the Regulations) • Schedule 2 of the Regulations. 11/10/2017 Devices Sponsor Information Day 33
  • 34. Checks to Do • Is the assigned GMDN code appropriate? (Section 10 of the Regulation)  Remember that manufacturer assign the GMDN code.  Check if the GMDN is on the TGA database. If the GMDN code is not in the TGA database, ask for it to be added in advance by email to ebs@tga.gov.au  There may be differences between the GMDN Agency code table database and the TGA code table database.  Based on the Device information, is the GMDN appropriate and reflects the intended purpose?  Must be a preferred term  Does the device perform according to its intended purpose?  This should be a detailed description of the manufacturers intended purpose and should closely align with the relevant GMDN description  Remember: Intended purpose is different from Functional description (describes the operation of the medical device, not its composition) 11/10/2017 Devices Sponsor Information Day 34
  • 35. Checks to Do ● Is the device same kind of medical device (Section 41BE of The Act)? A medical device is of the same ‘kind’ if it has the same:  Intended purpose  Classification  GMDN code  Legal manufacturer  Sponsor  Does it have appropriate evidence of Conformity Assessment?  ARGMD Section 5 Conformity Assessment Overview  Need to check the appropriate level and route is held by the manufacturer according to the classification 11/10/2017 Devices Sponsor Information Day 35
  • 36. Checks to Do 11/10/2017 Devices Sponsor Information Day 36
  • 37. Checks to Do There are a number of important details that a sponsor should check to ensure that the certificate is valid for particular devices. Refer to Section 7 of the ARGMD 11/10/2017 Devices Sponsor Information Day 37
  • 38. Additional Information If there is additional information that could help the assessor, then it would be beneficial to attach a ONE PAGE ONLY document with the application illustrating:  A Picture/diagram of the device  A description of the device (not the intended purpose)  A description of the mechanism of action (how it works)  How the device is included in the scope of the CE Certificate  Evidence of the same kind of medical device (for multiple devices) 11/10/2017 Devices Sponsor Information Day 38
  • 39. Non-mandatory audit  Any Device Application is subject to non-mandatory audit.  Be prepared to submit any documents from Level 1 or 2 audit list, as well as anything else you may need to show compliance with any of the Essential Principles or Conformity Assessment Procedures. Examples:  Compliance with Essential Principles  Notified Body audit reports to verify the validity of the EC Certificate  Product labelling and IFU  Explanation and justification of Classification  Recent Clinical Evaluation Report  Recent Risk Management File  Compliance with particular standards (or justification why it is not complied with)  Remember you declare you can submit in 20 days! 11/10/2017 Devices Sponsor Information Day 39
  • 40. Non-mandatory audit  Provides all items requested by the TGA  Electronic and easy to navigate (entire document):  Clear table of content (hyperlinking and bookmarking work!)  Text readable  Page numbers throughout  Up-to-date Clinical Evidence Report (signed by a clinical expert!)  Up-to-date Risk Management File  Well prepared submission will:  Allow the delegate to easily navigate and find information quickly.  Reduce the number of questions raised by the delegate  Speed approval The better quality the submission, the easier it is to read and evaluate 11/10/2017 Devices Sponsor Information Day 40
  • 41. Wrap Up  Make sure you understand your product.  Do your preparation and verify information before submission! Time spent before submitting is well worth it and will increase your success rate  Engage your cross function team (R&D/Quality/Medical/Clinical..etc) well in advance of your submission plan. Discuss application requirements and TGA’s expectation.  Submit meaningful, helpful and well-set out information. Perform second check before sending application and electronic files  Clearly explain the scope of your application in the cover letter  Provide comprehensive Table of Content  Ensure all hyperlinks and bookmarks are actually working  Ensure all documents and attachments are provided with the application!  Don’t submit extra documents that aren’t useful or haven’t been requested 11/10/2017 Devices Sponsor Information Day 41
  • 42. References The Act Therapeutic Goods Act 1989 The Regulations Therapeutic Goods (Medical Device) Regulations 2002 ARGMD Australian Regulatory Guidance for Medical Devices 11/10/2017 Devices Sponsor Information Day 42